Medical Notices




NEW ZEALAND GAZETTE

No. 62

1612

(a) the date of the election and the hour the poll will close;

(b) the date and the hour on which the nomination of candidates will close; and

(c) the prescribed form for nominations, as set out in rule 7 below.

  1. Candidates for election—(1) Every candidate for election must be nominated in writing in a form specified by the council, with respective registration number indicated, by 15 other registered medical practitioners eligible to vote.

(2) The nomination form—

(a) shall contain the registration number, full name and registered address of the registered medical practitioner nominated, the written consent of the nominee and a biographical sketch (maximum 450 100 words) in a format specified by the council and include details of any investigation of competence, complaint, health or disciplinary matter that if elected may bring the profession into disrepute, and

(b) may also shall include a statement to voters (maximum 100 words) prepared by the nominee and a recent photograph, and (remaining text unamended).

N.B.: These rules come into force on the day the rules, as approved by the Minister of Health, are published in the New Zealand Gazette.


Medicines Act 1981

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Apo-Fluoxetine
Active Ingredient: Fluoxetine hydrochloride 11.2mg equivalent to fluoxetine 10mg
Dosage Form: Capsule
New Zealand Sponsor: Apotex NZ Limited
Manufacturer: Apotex Inc, Weston, Ontario, Canada

Product: Apo-Ibuprofen
Active Ingredient: Ibuprofen 200mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Apotex NZ Limited
Manufacturer: Apotex Inc, Weston, Ontario, Canada

Product: Cyprostat-100
Active Ingredient: Cyproterone acetate 100mg
Dosage Form: Tablet
New Zealand Sponsor: Schering (NZ) Limited
Manufacturer: Schering SA, Lys Lez Lannoy, France

Product: Paracetamol (Amcal)
Active Ingredient: Paracetamol 500mg
Dosage Form: Tablet
New Zealand Sponsor: PSM Healthcare Limited
Manufacturer: PSM Healthcare Limited, Wiri, Auckland

Dated this 5th day of June 2002.

G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).


Consent to the Distribution of Changed Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:

Schedule

Product: Seretide Accuhaler
Active Ingredients: Fluticasone propionate 100µg
Salmeterol xinafoate 72.5µg equivalent to 50µg of salmeterol base
Dosage Form: Powder for inhalation
New Zealand Sponsor: Glaxo Wellcome New Zealand Limited
Manufacturer: Glaxo Wellcome Operations, Ware, Hertfordshire, United Kingdom



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2002, No 62


Gazette.govt.nz PDF NZ Gazette 2002, No 62





✨ LLM interpretation of page content

🏥 Amendments to Medical Practitioners Election Rules (continued from previous page)

🏥 Health & Social Welfare
6 June 2002
Medical Practitioners Act 1995, Election Rules, Amendments

🏥 Consent to the Distribution of New Medicines

🏥 Health & Social Welfare
5 June 2002
Medicines Act 1981, New Medicines, Distribution Consent
  • G. R. Boyd, Chief Advisor, Safety and Regulation

🏥 Consent to the Distribution of Changed Medicines

🏥 Health & Social Welfare
Medicines Act 1981, Changed Medicines, Distribution Consent